-+ 0.00%
-+ 0.00%
-+ 0.00%

TG THERAPEUTICS ANNOUNCES INITIATION OF PHASE 2 TRIAL EVALUATING BRIUMVI IN PATIENTS WITH TREATMENT-RESISTANT SCHIZOPHRENIA

Reuters·07/06/2026 11:30:01

Please log in to view news